NDC 0187-0730

WELLBUTRIN XL

Bupropion Hydrochloride

WELLBUTRIN XL is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Bausch Health Us Llc. The primary component is Bupropion Hydrochloride.

Product ID0187-0730_195ac110-0d0e-4f1c-aaae-7ff5bb41a0cf
NDC0187-0730
Product TypeHuman Prescription Drug
Proprietary NameWELLBUTRIN XL
Generic NameBupropion Hydrochloride
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2003-08-29
Marketing CategoryNDA / NDA
Application NumberNDA021515
Labeler NameBausch Health US LLC
Substance NameBUPROPION HYDROCHLORIDE
Active Ingredient Strength150 mg/1
Pharm ClassesAminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0187-0730-07

7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-07)
Marketing Start Date2003-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0187-0730-07 [00187073007]

WELLBUTRIN XL TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021515
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2003-08-29

NDC 0187-0730-90 [00187073090]

WELLBUTRIN XL TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021515
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2003-08-29

NDC 0187-0730-30 [00187073030]

WELLBUTRIN XL TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021515
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2003-08-29

Drug Details

Active Ingredients

IngredientStrength
BUPROPION HYDROCHLORIDE150 mg/1

OpenFDA Data

SPL SET ID:a435da9d-f6e8-4ddc-897d-8cd2bf777b21
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 993557
  • 993541
  • 993564
  • 993545

    • Pharmacological Class

    • Aminoketone [EPC]
    • Dopamine Uptake Inhibitors [MoA]
    • Increased Dopamine Activity [PE]
    • Increased Norepinephrine Activity [PE]
    • Norepinephrine Uptake Inhibitors [MoA]

    NDC Crossover Matching brand name "WELLBUTRIN XL" or generic name "Bupropion Hydrochloride"

    NDCBrand NameGeneric Name
    21695-138WELLBUTRIN XLWELLBUTRIN XL
    21695-137WELLBUTRIN XLWELLBUTRIN XL
    0187-0731WELLBUTRIN XLWELLBUTRIN XL
    0187-0730WELLBUTRIN XLWELLBUTRIN XL
    0115-5445Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
    0115-6811Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
    0185-0410Bupropion HydrochlorideBupropion Hydrochloride
    0185-0415Bupropion HydrochlorideBupropion Hydrochloride
    0185-1111Bupropion HydrochlorideBupropion Hydrochloride
    0173-0135WELLBUTRINbupropion hydrochloride
    0173-0722WELLBUTRINbupropion hydrochloride
    0173-0947WELLBUTRINbupropion hydrochloride
    0173-0556ZYBANbupropion hydrochloride

    Trademark Results [WELLBUTRIN]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    WELLBUTRIN
    WELLBUTRIN
    73239586 1160590 Live/Registered
    Burroughs Wellcome Co.
    1979-11-19
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.